Safety And Therapeutic Measures Of Transcranial Cathodal Direct Current Stimulation (Tdcs) In Patients With Refractory Focal Epilepsy
Recruiting
9-99 years
All
Phase
3
8 participants needed
1 Location
Brief description of study
The study aims to evaluate the safety, tolerability and efficacy of repeated, daily sessions of transcranial cathodal direct current simulation (tDCS) as administered by the10 STARSTIM (tDCS) device in 10 consecutive days of in-office treatment sessions.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Epilepsy
-
Age: Between 9 Years - 99 Years
-
Gender: All
Male or Female, Age 9 or older, Diagnosis of epilepsy with focal seizures
Updated on
01 Aug 2024.
Study ID: 849985
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
